Diversity in Cardiovascular Disease: Are We Failing the General Population?
Published: 15 April 2024
-
Views:
7279 -
Likes:
7
-
Views:
7279 -
Likes:
7
-
3m 23sPart 1 Payer Rejections' Impact on Bempedoic Acid Access: Patient Costs Martha Gulati
-
3m 15sPart 2 Hispanic/Latinx Participants' Bempedoic Acid Outcomes: CLEAR Analysis Martha Gulati
Overview
In this video series recorded at ACC 2024 in Atlanta, US, Prof Martha Gulati (Cedars-Sinai Smidt Heart Institute, Los Angeles, US) unveils pivotal data from four posters addressing the pressing issue of inequality in cardiology and healthcare. Gain a deeper understanding of personalised treatment approaches, recognise the importance of inclusivity in clinical trials and confront disparities in accessing innovative treatments. Join us to discover actionable strategies to bridge gaps in cardiovascular care.
Learning Objectives
- Recall emerging clinical research addressing patient inequity in cardiovascular disease treatment and prevention
- Apply individualised treatment strategies to specific patient sub-groups
More from this programme
Part 1
Poster One
Part 2
Poster Two
Part 3
Poster Three
Part 4
Poster Four
Faculty Biographies
Martha Gulati
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC is the President-Elect of the American Society for Preventive Cardiology. She was a Professor of Medicine and the inaugural Chief of Cardiology at the University of Arizona. Previously, she held the Sarah Ross Soter Chair in Women’s Cardiovascular Health and was the Section Director for Women’s Cardiovascular Health and Preventive Cardiology at The Ohio State University until 2015. She is the author of the best-seller, “Saving Women’s Hearts”. She is the Editor-in-Chief of the American College of Cardiology “CardioSmart”, the patient education and empowerment initiative. She serves as the chair of the national chest pain guidelines that will be released in 2021.
Her exceptional commitment to the study of women and cardiac diseases has won her numerous awards and distinctions, including being named by Crain’s Chicago Business…
Comments